2014 studies found for:    Open Studies | "Hematologic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Integrated Whole-Genome Analysis of Hematologic Disorders
Condition: Hematologic Diseases
Interventions: Procedure: Blood Draw;   Procedure: Skin Biopsy
2 Not yet recruiting The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study
Condition: Hematologic Diseases
Intervention: Other: Touch-massage
3 Recruiting Evaluation of Patients With Blood Disorders
Condition: Hematologic Disease
Intervention:
4 Recruiting Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
Conditions: Hematologic Disease;   Lymphoma;   Multiple Myeloma;   Myelodysplastic Syndrome;   Myeloproliferative Disorder
Intervention: Procedure: Stem cell transplantation
5 Recruiting Evaluation, Treatment, and Training for Patients With Blood Disorders
Conditions: Hematologic Disease;   Hematologic Neoplasm;   Pancytopenia
Intervention:
6 Recruiting Hematology Biobank : Invitro Study of Blood Disorders
Condition: Hematological Disorders
Intervention:
7 Recruiting Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery
Conditions: Blood and Blood Disorders;   Anemia, Neonatal;   Hematologic Disease;   Infant, Newborn, Diseases
Intervention: Procedure: Fetoscopic laser surgery
8 Unknown  Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
Condition: Febrile Neutropenia
Interventions: Drug: ciprofloxacin;   Drug: cefepime
9 Recruiting Stem Cell Transplant for Patients With Sickle Cell Disease (SCD), Thalassemia, Diamond Blackfan Anemia (DBA) and Other Non-malignant (Non-cancerous) Hematologic Disorders
Conditions: Sickle Cell Disease;   Thalassemia;   Diamond Blackfan Anemia;   Non-malignant Hematologic Disorders
Interventions: Drug: Anti-thymocyte globulin (ATG);   Drug: Fludarabine monophosphate;   Drug: Busulfan;   Drug: Alemtuzumab;   Drug: Cyclophosphamide;   Drug: Mesna;   Radiation: total body irradiation
10 Recruiting Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients
Conditions: Hematological Disease;   Delayed Gastric Emptying;   Malignant Disease
Intervention: Other: dietary counselling
11 Unknown  Registry of Febrile Neutropenia and Invasive Fungal Infections
Conditions: Hematological Disease;   Febrile Neutropenia;   Fungal Infections
Intervention: Other: Patient registry
12 Recruiting A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Conditions: Primary Myelofibrosis;   Thrombocythemia, Essential;   Thrombocytosis;   Myeloproliferative Disorders;   Bone Marrow Diseases;   Hematologic Diseases;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hemorrhagic Disorders
Interventions: Drug: LDE225;   Drug: INC424
13 Recruiting Bone Marrow Grafting for Leukemia and Lymphoma
Conditions: Leukemia;   Lymphoma;   Hematologic Diseases
Intervention: Procedure: collection and storage of tissue samples for research
14 Recruiting Gulf Long-Term Follow-Up Study
Conditions: Cardiovascular Disease;   Hematologic Diseases;   Immunologic Disease;   Cancer;   Respiratory Function
Intervention:
15 Recruiting Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells
Condition: Hematologic Diseases
Intervention:
16 Recruiting Transplants With Unlicensed Preserved Cord Blood
Conditions: Myelodysplastic Syndrome (MDS);   Hematologic Neoplasms;   Hematologic Diseases;   Severe Aplastic Anemia
Intervention: Procedure: Cord Blood Transplant
17 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
Intervention:
18 Unknown  Intra Bone Marrow Injection Of Unrelated Cord Blood Cells
Condition: Hematologic Diseases
Intervention: Procedure: Intrabone Marrow Injection
19 Not yet recruiting Registry of Philadelphia-Negative Myeloproliferative Neoplasms
Condition: Hematologic Diseases
Intervention:
20 Recruiting Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.
Conditions: Leukemia;   Leukemia,Pediatric;   Leukemia, Myleiod;   Leukemia, Mylegenous, Chronic;   Leukemia, Mylegenous, Accelerated;   BCR-ABL Positive;   Myeloproliferative Disorder;   Bone Marrow Disease;   Hematologic Diseases;   Neoplastic Processes;   Imatinib;   Dasatinib;   Enzyme Inhibitor;   Protein Kinase Inhibitor
Intervention: Drug: nilotinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years